Evidence map›Paper›PMID 34427507›Full record

ArticlemSystems2021

Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris.

Daniel Zamith-Miranda, Heino M Heyman, Sneha P Couvillion, Radames J B Cordero, Marcio L Rodrigues, Leonardo Nimrichter, Arturo Casadevall, Rafaela F Amatuzzi, Lysangela R Alves, Ernesto S Nakayasu and 1 more

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Extracellular Vesicles fromPathogens (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Extracellular vesicles ofInfection and immunity · 2026
    Article
  7. Review
  8. Caspofungin Reshapes the Extracellular Vesicles Metabolome ofJournal of fungi (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Functional properties ofMicrobiology (Reading, England) · 2025
    Article
  17. Article
  18. Interactions of the emerging fungusMicrobiology spectrum · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Daniel Zamith-MirandaDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Heino M HeymanBiological Sciences Division, Pacific Northwest National Laboratorygrid.451303.0, Richland, Washington, USA.
Sneha P CouvillionBiological Sciences Division, Pacific Northwest National Laboratorygrid.451303.0, Richland, Washington, USA.
Radames J B CorderoHarry Feinstone Molecular Microbiology and Immunology Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Marcio L RodriguesCarlos Chagas Institute, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
Leonardo NimrichterMicrobiology Institute Paulo de Góes (IMPG), Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Arturo CasadevallHarry Feinstone Molecular Microbiology and Immunology Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Rafaela F AmatuzziCarlos Chagas Institute, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
Lysangela R AlvesCarlos Chagas Institute, Fundação Oswaldo Cruz (Fiocruz), Curitiba, Brazil.
Ernesto S Nakayasu *Biological Sciences Division, Pacific Northwest National Laboratorygrid.451303.0, Richland, Washington, USA.
Joshua D Nosanchuk *Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
Pacific Northwest National Laboratory · USAlbert Einstein College of Medicine · USFundação Oswaldo Cruz · BRJohns Hopkins University · USUniversidade Federal do Rio de Janeiro · BR

Funding

Synergy of Host Defense Mechanisms in the LungR01HL059842 · NHLBI · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 1997 to 2023
$7.4M
Biology of Fungal MelaninR01AI052733 · NIAID · YESHIVA UNIVERSITY · PI CASADEVALL, ARTURO · 2003 to 2019
$6.6M
Lacrimal Gland Repair Using Progenitor CellsR01EY026202 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI MAKARENKOVA, HELEN P. · 2016 to 2025
$5.2M
Antibody differentially alters Histoplasma extracellular vesiclesR21AI124797 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI NOSANCHUK, JOSHUA D · 2016 to 2017
$538k
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ) E-26/202.809/2018Fundação Oswaldo Cruz (FIOCRUZ) PROEP-ICC 442186/2019-3HHS | National Institutes of Health (NIH) AI052733MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 311179/2017-7MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 405520/2018-2Ministério da Saúde (Ministry of Health) 440015/2018-9NHLBI NIH HHS R01 HL059842NIAID NIH HHS R01 AI052733NIAID NIH HHS R21 AI124797
6 · The paper itself

Abstract

Candida auris is a recently described multidrug-resistant pathogenic fungus that is increasingly responsible for health care-associated outbreaks across the world. Bloodstream infections of this fungus cause death in up to 70% of cases. Aggravating this scenario, the disease-promoting mechanisms of C. auris are poorly understood. Fungi release extracellular vesicles (EVs) that carry a broad range of molecules, including proteins, lipids, carbohydrates, pigments, and RNA, many of which are virulence factors. Here, we carried out a comparative molecular characterization of C. auris and Candida albicans EVs and evaluated their capacity to modulate effector mechanisms of host immune defense. Using proteomics, lipidomics, and transcriptomics, we found that C. auris released EVs with payloads that were significantly different from those of EVs released by C. albicans. EVs released by C. auris potentiated the adhesion of this yeast to an epithelial cell monolayer, while EVs from C. albicans had no effect. C. albicans EVs primed macrophages for enhanced intracellular yeast killing, whereas C. auris EVs promoted survival of the fungal cells. Moreover, EVs from both C. auris and C. albicans induced the activation of bone marrow-derived dendritic cells. Together, our findings show distinct profiles and properties of EVs released by C. auris and by C. albicans and highlight the potential contribution of C. auris EVs to the pathogenesis of this emerging pathogen.

Indexed as

Candida albicansCandida auriscandidiasisextracellular vesiclesfungal pathogenesismulti-omics

Identifiers

PMID34427507
PMCPMC8407381
OpenAlexW3194228884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.